Literature DB >> 18615777

Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation.

Winston Costa Pereira1, Italia Khushnooma, Manisha Madkaikar, K Ghosh.   

Abstract

Mesenchymal stem cells (MSCs) are considered to be a source of stem cells in tissue regeneration and therapeutics, due to their ability to undergo proliferation and differentiation. Complications associated with bone marrow-derived MSCs has prompted researchers to explore alternative sources of MSCs. The human umbilical cord is one such source; it is easily available and its collection is non-invasive. The sources of MSCs are non-controversial and thus they are not subjected to ethical constraints, as in the case of embryonic stem cells. MSCs are multipotent stem cells and has the ability to differentiate into various cell types of the mesodermal lineage. The aim of this study was to establish a reproducible method for the isolation of MSCs from human umbilical cord, as the few methods published till date gave inconsistent results and had a mixed population of contaminating endothelial cells. In our isolation strategy, we isolated a pure population of MSCs from Wharton's jelly of the human umbilical cord, which is very rich in collagen, and we used a high concentration of collagenase enzyme in the isolation of MSCs. Extensive phenotypic characterization analysis of these cells, using flow cytometry and antibody staining methods, have shown that we were able to isolate a pure population of the mesenchymal lineage cells that is devoid of haematopoietic and endothelial cell contaminants. When these MSCs were subjected to cardiomyocyte differentiation, we observed a change in the morphological characteristics, which was accompanied by the formation of myotube structures and spontaneous beating after 21 days. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615777     DOI: 10.1002/term.107

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  27 in total

1.  Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.

Authors:  Baskar Subramani; Sellamuthu Subbannagounder; Sekar Palanivel; Chithra Ramanathanpullai; Sivakumar Sivalingam; Azhari Yakub; Manjunath SadanandaRao; Arivudainambi Seenichamy; Ashok Kumar Pandurangan; Jun Jie Tan; Rajesh Ramasamy
Journal:  Cytotechnology       Date:  2016-01-28       Impact factor: 2.058

Review 2.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

3.  Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications.

Authors:  Anastasia Petsa; Sofia Gargani; Antigonos Felesakis; Nikolaos Grigoriadis; Ioannis Grigoriadis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

4.  Inhibitor of p53-p21 pathway induces the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyogenic cells.

Authors:  Zhong-Bao Ruan; Li Zhu; Yi-Gang Yin; Ge-Cai Chen
Journal:  Cytotechnology       Date:  2015-06-05       Impact factor: 2.058

Review 5.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 6.  Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.

Authors:  Jia-Wen Si; Xu-Dong Wang; Steve Gf Shen
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

7.  Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.

Authors:  Alp Can; Ahmet Tulga Ulus; Ozgur Cinar; Ferda Topal Celikkan; Erdal Simsek; Mesut Akyol; Ugur Canpolat; Murat Erturk; Fadil Kara; Osman Ilhan
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

8.  Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair.

Authors:  Cetin Kocaefe; Deniz Balci; Burcu Balci Hayta; Alp Can
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

9.  Human umbilical cord-derived MSC culture: the replacement of animal sera with human cord blood plasma.

Authors:  Yan Ding; Hua Yang; Jing Bo Feng; Ying Qiu; Dong Sheng Li; Yi Zeng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-09-17       Impact factor: 2.416

Review 10.  Mechanobiology of cardiomyocyte development.

Authors:  Jeffrey G Jacot; Jody C Martin; Darlene L Hunt
Journal:  J Biomech       Date:  2009-10-12       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.